MedPath

MOHAMMED MILHEM

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Seleno-L Methionine (SLM)-Axitinib-Pembrolizumab

Phase 1
Recruiting
Conditions
Clear Cell Renal Cell Carcinoma
Clear Cell Renal Cell Carcinoma Metastatic
Interventions
First Posted Date
2022-05-06
Last Posted Date
2025-03-10
Lead Sponsor
Mohammed Milhem
Target Recruit Count
55
Registration Number
NCT05363631
Locations
🇺🇸

University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States

Chlorpromazine and Standard of Care in Glioblastoma

Phase 1
Active, not recruiting
Conditions
Glioblastoma Multiforme
Interventions
Radiation: Radiation Therapy
First Posted Date
2022-01-13
Last Posted Date
2023-08-29
Lead Sponsor
Mohammed Milhem
Target Recruit Count
10
Registration Number
NCT05190315
Locations
🇺🇸

University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States

High Dose Ascorbate With Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas

Phase 1
Completed
Conditions
Soft Tissue Sarcoma
Interventions
First Posted Date
2018-04-26
Last Posted Date
2024-06-27
Lead Sponsor
Mohammed Milhem
Target Recruit Count
25
Registration Number
NCT03508726
Locations
🇺🇸

University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States

Anti-Osteoclast Therapy as Neoadjuvant in Treatment of Chondrosarcoma - Phase 1b Trial

Phase 1
Active, not recruiting
Conditions
Chondrosarcoma
Interventions
First Posted Date
2017-06-02
Last Posted Date
2024-05-30
Lead Sponsor
Mohammed Milhem
Target Recruit Count
17
Registration Number
NCT03173976
Locations
🇺🇸

University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States

Decitabine and Gemcitabine for Pancreatic Cancer and Sarcoma

Phase 1
Completed
Conditions
Pancreatic Ductal Adenocarcinoma
Sarcoma
Interventions
First Posted Date
2016-11-08
Last Posted Date
2023-07-28
Lead Sponsor
Mohammed Milhem
Target Recruit Count
36
Registration Number
NCT02959164
Locations
🇺🇸

University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States

SLM + Axitinib for Clear Cell RCC

Phase 1
Completed
Conditions
Advanced Metastatic Clear Cell Renal Cell Carcinoma (CCRCC)
Interventions
First Posted Date
2015-08-28
Last Posted Date
2025-05-20
Lead Sponsor
Mohammed Milhem
Target Recruit Count
46
Registration Number
NCT02535533
Locations
🇺🇸

University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States

© Copyright 2025. All Rights Reserved by MedPath